Trial Profile
INVESTIGATION OF THE EFFICACY OF LAPATINIB MONOTHERAPY AND TEMOZOLOMIDE PLUS LAPATINIB COMBINATION, IN RECURRENT HIGH GRADE GLIOMAS. A PHASE I/II STUDY.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 31 Jul 2015
Price :
$35
*
At a glance
- Drugs Lapatinib (Primary) ; Temozolomide (Primary)
- Indications Glioma
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 26 Jul 2011 New trial record